Snowe/Wyden Has Industry, AARP Support; Bilirakis Plan Is PhRMA-Pleaser
Executive Summary
Sens. Snowe (R-Maine) and Wyden (D-Ore.) are boasting a wide range of support, spanning different industry segments and an important elderly advocacy group, for a Medicare drug benefit modeled after the Federal Employees Health Benefit Program.
You may also be interested in...
HIAA Suggests 35% Of Elderly Could Get Rx Benefits Thru State Programs
Approximately 35% of Medicare eligibles would receive assistance for outpatient drug purchases through state programs funded by federal block grants in a Medicare proposal being developed by the Health Insurance Association of America.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011